Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Overcoming Commercial, Technical & Regulatory Challenges in Drug Discovery
Posted on August 16th, 2017 by Christine de Vries - Scheidegger in Chemistry
R&D departments find themselves having to work with budgets that seem to get tighter all the time. One of the best ways of ensuring that investments are used on projects with the greatest probability of success is to discover as early as possible when a project is not going anywhere and halt it.
“ScienceDirect is very important to drug discovery and development. There isn’t a scientist I’ve worked with who don’t tap almost daily into this information source. It has an impact on almost every drug that comes to market. ”
—Ken Balthis, Senior Executive Director
By turning to the literature across all disciplines in one place, R&D teams can look at other studies to glean insights that will help them make the best decisions and avoid making mistakes. A Senior Executive Director explains how ScienceDirect gives his team access to peer-reviewed scientific literature as they work to identify new technologies.
ScienceDirect helps determine a drug’s technical and commercial feasibility by providing access to relevant studies and data, as well as improve the likelihood of regulatory approval. ScienceDirect proves to be one of the most ‘go to’ information sources for his team’s success—helping to improve the viability and commercial success rates of new and innovative drugs in their R&D pipeline.
All opinions shared in this post are the author’s own.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Christine de Vries - Scheidegger
Head of Market Development, Corporate R&D at Elsevier
- Small Biotechs Progressing Beyond Startup Status
- Managing Data and the Digital Revolution with Emerging Technologies
- Artificial Intelligence Comes to the Life Sciences
- Seeing Research Through a Scientist’s Eyes
- The Hive is open for 2017 applicants